Pascale MD - Poxel SA CoFounder Affairs
| POXEL Stock | EUR 0.23 0.00 0.00% |
Insider
Pascale MD is CoFounder Affairs of Poxel SA
| Phone | 33 4 37 37 20 10 |
| Web | https://www.poxelpharma.com |
Poxel SA Management Efficiency
The company has return on total asset (ROA) of (0.3038) % which means that it has lost $0.3038 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.2337) %, meaning that it generated substantial loss on money invested by shareholders. Poxel SA's management efficiency ratios could be used to measure how well Poxel SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Martin Zouhar | SEB SA | N/A | |
| Cyril Buxtorf | SEB SA | 57 | |
| Philippe Sumeire | SEB SA | 61 | |
| Alexandre Merieux | Biomerieux SA | 49 | |
| Frederic Beseme | Biomerieux SA | 67 | |
| Isabelle Posth | SEB SA | N/A | |
| Sylvain Morgeau | Biomerieux SA | N/A | |
| David Bryant | Eurofins Scientific SE | N/A | |
| Nathalie Lomon | SEB SA | 52 | |
| Delphine Vaylet | SEB SA | 53 | |
| Yasha Mitrotti | Biomerieux SA | N/A | |
| Sandra Hoeylaerts | Eurofins Scientific SE | N/A | |
| Guillaume Bouhours | Biomerieux SA | 47 | |
| Stanislas Gramont | SEB SA | 57 | |
| Benedikt Orzelek | Sartorius Stedim Biotech | N/A | |
| Heiko Imhl | Sartorius Stedim Biotech | N/A | |
| Pierre Boulud | Biomerieux SA | 52 | |
| Joachim Kreuzburg | Sartorius Stedim Biotech | 58 | |
| Valerie Leylde | Biomerieux SA | N/A | |
| Giles Pelissier | SEB SA | N/A | |
| Mark Miller | Biomerieux SA | N/A | |
Management Performance
| Return On Equity | -3.23 | |||
| Return On Asset | -0.3 |
Poxel SA Leadership Team
Elected by the shareholders, the Poxel SA's board of directors comprises two types of representatives: Poxel SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Poxel. The board's role is to monitor Poxel SA's management team and ensure that shareholders' interests are well served. Poxel SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Poxel SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Quentin Durand, Chief VP | ||
| Bolze PharmD, COO CoFounder | ||
| Sylvie Bertrand, VP HR | ||
| Pascale MD, CoFounder Affairs | ||
| Noah MBA, Exec Operations | ||
| Sophie HallakouBozec, CoFounder Communication | ||
| Elizabeth MBA, Corp Relations | ||
| MBA PharmD, CEO CoFounder | ||
| David MD, Ex Officer | ||
| Anne Renevot, Ex CFO |
Poxel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Poxel SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.23 | |||
| Return On Asset | -0.3 | |||
| Operating Margin | (134.99) % | |||
| Current Valuation | 51.26 M | |||
| Shares Outstanding | 30.83 M | |||
| Shares Owned By Insiders | 9.84 % | |||
| Shares Owned By Institutions | 23.08 % | |||
| Price To Earning | 13.09 X | |||
| Price To Book | 5.34 X | |||
| Price To Sales | 162.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Poxel Stock Analysis
When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.